• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Streamex Corp. (NASDAQ: STEX) to Provide Corporate Update Webinar Highlighting 2025 Milestones and 2026 Strategic Roadmap on December 16th at 11:00am EST

    12/12/25 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $STEX alert in real time by email

    LOS ANGELES, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization and digital asset infrastructure, today announced that it will host a corporate update webinar on December 16, 2025 at 11:00 AM EST. The event will provide shareholders with a comprehensive review of the company's 2025 achievements, an update on the GLDY launch, and an overview of the Company's strategic roadmap for 2026 and beyond.

    Webinar Registration

    To join the Streamex Investor Webinar please register at the link below:

    https://us06web.zoom.us/webinar/register/WN_4GJskoJHQDaPimhx7NS1uw

    CEO & Chairman Commentary

    "The second half of 2025 saw a number of important milestones achieved by Streamex. We are extraordinarily proud of our team and encouraged by the positive catalysts we see for 2026," said Henry McPhie, Co-Founder & CEO and Morgan Lekstrom, Co-Founder & Chairman of Streamex. "With the launch of GLDY, we are not simply tokenizing gold; we're fundamentally transforming how institutional investors can access yield-bearing precious metals. GLDY represents institutional-grade tokenization at scale. Our existing partnerships and team combined with our strong capital position, will enable us to consistently scale over the next several years from the initial GLDY issuance. Moreover, GLDY sets a precedent for future RWA token launches for additional commodities with yield and more."

    Corporate Update Overview

    2025 Strategic Achievements

    Building a World-Class Team & Advisory Network

    Streamex expanded its leadership and advisory capabilities with seasoned industry executives, including:

    • Strategic Advisor: Frank Giustra (Wheaton Precious Metals, GoldCorp)
    • Strategic Advisor: Sean Roosen (Osisko Group)
    • Chief Investment Officer: Mitch Williams, CFA (formerly OppenheimerFunds and Wafra Inc.)
    • Strategic Advisors: Mathew August, Trevor Bacon, and Kellen Grenier
    • Board Member: Kevin Gopaul (formerly Global Head of ETFs, CIO and Canadian CEO at BMO Global Asset Management)
    • General Counsel: Michael Frisch (Croke Fairchild Duarte & Beres LLC, formerly CFTC)



    Expanding Institutional Partnerships

    • Monetary Metals – Exclusive three-year partnership enabling yield-bearing precious metals products offering up to 4% annualized returns.
    • Simplify Asset Management – Letter of Intent to integrate GLDY into ETF structures and co-develop tokenized exchange-traded products.
    • Chainlink – Official Oracle Provider for GLDY with Proof of Reserves, CCIP and Price Feeds.
    • Solana Policy Institute – Participation in the Project Open Coalition to advance regulated on-chain trading of real-world assets.



    Strengthened Capital Position for Long-Term Growth

    Streamex enters 2026 with a strong, well-capitalized balance sheet, giving the Company the resources to scale for years to come.

    This capital foundation allows Streamex to accelerate product development, scale GLDY and future RWA token launches, and confidently execute its long-term strategic roadmap with financial stability and operational flexibility.

    Strategic Equity Stake in Empress Royalty Corp.

    Streamex acquired a 9.9% equity interest in Empress Royalty Corp., a global precious metals royalty and streaming firm. The transaction strengthens Streamex's exposure to gold and silver royalty assets and aligns tightly with its long-term strategy of building a diversified, institutional-grade real-world asset (RWA) platform.

    GLDY Launch

    The GLDY pre-sale began on November 10, 2025, with an initial issuance goal of $100 million (expandable to $300 million) and an anticipated Q1 2026 launch. Streamex has observed strong early indications of investor interest and will provide additional updates during the webinar.

    Each GLDY token represents one fine troy ounce of physical gold bullion with no annual storage fees or bid-ask spreads, accruing yield at up to 4% annualized paid in additional ounces of gold via additional GLDY tokens. Streamex intends to commit a minimum of $5 million to purchase GLDY tokens as an anchor investor.

    GLDY is issued as a Reg D restricted security, designed for institutional and accredited investors with minimum subscriptions of $200,000 USD for individuals and $1 million USD for institutions. The offering provides investors access to yield-bearing, verified physical gold holdings with monthly distributions automatically distributed as additional GLDY tokens, transforming gold from a static store of value into a productive, income-generating asset.

    Strategic Roadmap for 2026 and Beyond

    Streamex's long-term product roadmap is guided by a core corporate philosophy: to pursue value-added structured solutions that unlock the full potential of commodity assets through tokenization. Rather than simply digitizing assets, Streamex designs products that enhance the underlying economic utility of commodities and commodity assets, turning traditionally static holdings into potentially yield-generating and institutionally scalable financial instruments. This approach modernizes commodity financing, improves capital efficiency for market participants, and establishes a superior alternative to conventional tools such as futures, options, physical storage-based products and equities.

    This approach:

    • Disrupts traditional futures, options and ETF markets
    • Provides superior working-capital solutions to commodity-intensive industries
    • Creates attractive economics for Streamex while delivering value added products to investors



    Planned Tokenization Initiatives

    While the team remains focused on executing the GLDY launch, Streamex's broader corporate strategy includes a clear and deliberate roadmap for expanding its real-world asset tokenization platform. Building on the GLDY framework, Streamex plans to introduce a series of value-added, tokenized commodity products across multiple categories, including:

    • Silver with yield (2026)
    • Royalties and streams (2026)
    • Copper with yield (2027)
    • Oil & Gas with yield (2027–2028)



    These planned product launches represent the next phase of Streamex's ambition to develop a full-spectrum, institutional-grade on-chain commodities capital markets infrastructure. At the same time, the Company anticipates that other tokenization opportunities may be added to the roadmap as market conditions evolve. Streamex will pursue products that are most economically accretive and strategically aligned with its value-added tokenization philosophy. With the GLDY infrastructure now in place, Streamex is positioned to accelerate the pace at which new tokens can be brought to market.

    About Streamex Corp.

    Streamex Corp. (NASDAQ:STEX) is a vertically integrated technology and infrastructure company focused on the tokenization and digitalization of real-world assets. Streamex provides institutional-grade solutions that bring traditional commodities and assets on-chain through secure, regulated, and yield-bearing financial instruments. The company is committed to delivering transparent, scalable, and compliant digital asset solutions that bridge the gap between traditional finance and blockchain-enabled markets.

    For more information, visit www.streamex.com or follow the company on X (Twitter) at @streamex.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding Streamex's corporate strategy, expected product launches, and future operations. These statements involve risks and uncertainties that may cause actual results to differ materially. Streamex undertakes no obligation to update these forward-looking statements except as required by law.

    Contacts

    Streamex Press & Investor Relations

    Adele Carey – Alliance Advisors Investor Relations

    IR@streamex.com | acarey@allianceadvisors.com

    Henry McPhie

    Chief Executive Officer, Streamex Corp.

    contact@streamex.com | www.streamex.com | X.com/streamex



    Primary Logo

    Get the next $STEX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $STEX

    DatePrice TargetRatingAnalyst
    11/25/2025$12.00Buy
    Needham
    More analyst ratings

    $STEX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Gopaul Kevin Roy

    3 - Streamex Corp. (0001530766) (Issuer)

    12/11/25 5:15:26 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    CFO Groenewald Ferdinand was granted 60,000 shares, increasing direct ownership by 26% to 295,000 units (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    11/21/25 4:35:48 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Lekstrom Morgan Lee bought $25,060 worth of shares (7,000 units at $3.58) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    11/21/25 12:44:17 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham initiated coverage on Streamex Exchange Corporation with a new price target

    Needham initiated coverage of Streamex Exchange Corporation with a rating of Buy and set a new price target of $12.00

    11/25/25 7:59:34 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    SEC Filings

    View All

    $STEX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SEC Form EFFECT filed by Streamex Corp.

    EFFECT - Streamex Corp. (0001530766) (Filer)

    12/11/25 12:15:05 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form S-3/A filed by Streamex Corp.

    S-3/A - Streamex Corp. (0001530766) (Filer)

    12/8/25 9:13:52 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form DEF 14A filed by Streamex Corp.

    DEF 14A - Streamex Corp. (0001530766) (Filer)

    11/20/25 4:00:43 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. (NASDAQ: STEX) to Provide Corporate Update Webinar Highlighting 2025 Milestones and 2026 Strategic Roadmap on December 16th at 11:00am EST

    LOS ANGELES, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization and digital asset infrastructure, today announced that it will host a corporate update webinar on December 16, 2025 at 11:00 AM EST. The event will provide shareholders with a comprehensive review of the company's 2025 achievements, an update on the GLDY launch, and an overview of the Company's strategic roadmap for 2026 and beyond. Webinar Registration To join the Streamex Investor Webinar please register at the link below: https://us06web.zoom.us/webinar/register/WN_4GJskoJHQDaPimhx7NS1uw CEO & Chairman Commentary "The second half of

    12/12/25 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. (NASDAQ: STEX) Acquires 9.9% Strategic Equity Stake in Royalty and Streaming Firm Empress Royalty Corp. Through a Premium Priced Share-for-Share Transaction at US$5.00 STEX with a Leading Institutional Investment Firm

    LOS ANGELES, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization and real-world asset infrastructure, today announced that it has acquired a 9.9% equity interest in Empress Royalty Corp. ("Empress") (TSXV:EMPR) through a strategic share purchase from Terra Capital Natural Resources Fund Pty Ltd. ("Terra Capital"), a prominent institutional investor. Under the executed Share Purchase Agreement, Streamex acquired 12,671,297 common shares of Empress in exchange for 2,443,750 restricted common shares of Streamex at a US$5.00 STEX share price, representing a premium to the current market price of STEX and an

    12/11/25 8:00:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. (NASDAQ: STEX) Joins Solana Policy Institute in the Project Open Coalition to Advance Regulated On-Chain Trading of Real-World Assets, Including GLDY

    LOS ANGELES, Dec. 10, 2025 (GLOBE NEWSWIRE) --  Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization of real-world assets, today announced it has joined Project Open, a landmark initiative working to establish a regulated framework for the issuance and trading of securities on public blockchains. The effort aims to unlock billions in traditional asset value through 24/7 trading, instant settlement, lower costs, and enhanced transparency for all real-world assets, while keeping the United States competitive in financial innovation. Streamex joins Solana Policy Institute united to drive the next era of compliant digital market infrastructur

    12/10/25 8:00:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Lekstrom Morgan Lee bought $25,060 worth of shares (7,000 units at $3.58) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    11/21/25 12:44:17 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Leadership Updates

    Live Leadership Updates

    View All

    Streamex Corp. (NASDAQ: STEX) Joins Solana Policy Institute in the Project Open Coalition to Advance Regulated On-Chain Trading of Real-World Assets, Including GLDY

    LOS ANGELES, Dec. 10, 2025 (GLOBE NEWSWIRE) --  Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization of real-world assets, today announced it has joined Project Open, a landmark initiative working to establish a regulated framework for the issuance and trading of securities on public blockchains. The effort aims to unlock billions in traditional asset value through 24/7 trading, instant settlement, lower costs, and enhanced transparency for all real-world assets, while keeping the United States competitive in financial innovation. Streamex joins Solana Policy Institute united to drive the next era of compliant digital market infrastructur

    12/10/25 8:00:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. (NASDAQ: STEX) Announces Appointment of Kevin Gopaul, Global Financial Executive and ETF Pioneer to Its Board of Directors

    LOS ANGELES, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization and digital asset infrastructure, today announced the appointment of Kevin Gopaul, global financial executive and pioneering leader in the exchange-traded fund (ETF) industry, to its Board of Directors, effective immediately. Kevin brings more than 25 years of global asset management and capital markets experience, including senior leadership roles as Global Head of ETFs, Chief Investment Officer, and Canadian CEO at BMO Global Asset Management, where he helped architect and scale the firm's $100 billion ETF franchise. He currently serves

    11/18/25 8:09:24 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Financials

    Live finance-specific insights

    View All

    Streamex Corp. (NASDAQ: STEX) Acquires 9.9% Strategic Equity Stake in Royalty and Streaming Firm Empress Royalty Corp. Through a Premium Priced Share-for-Share Transaction at US$5.00 STEX with a Leading Institutional Investment Firm

    LOS ANGELES, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization and real-world asset infrastructure, today announced that it has acquired a 9.9% equity interest in Empress Royalty Corp. ("Empress") (TSXV:EMPR) through a strategic share purchase from Terra Capital Natural Resources Fund Pty Ltd. ("Terra Capital"), a prominent institutional investor. Under the executed Share Purchase Agreement, Streamex acquired 12,671,297 common shares of Empress in exchange for 2,443,750 restricted common shares of Streamex at a US$5.00 STEX share price, representing a premium to the current market price of STEX and an

    12/11/25 8:00:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. (NASDAQ: STEX) Announces Launch of $100,000,000 USD GLDY Pre-Sale – A Gold-Backed Yield Generating Stablecoin Offering Institutional Yield on Physical Gold Bullion

    The launch of Streamex's $100 million USD GLDY pre-sale marks a historic opportunity for gold investors. Investing in gold is no longer just a static store of value, Streamex, through GLDY has created a yield-generating, institutional grade asset designed to offer both spot gold exposure and yield paid in additional ounces of physical gold bullion.  Key Highlights Gold Price Exposure and Gold-Denominated Distributions: GLDY is designed to combine audited physical bullion holdings with yield from institutionally managed gold leases sourced through Monetary Metals. GLDY seeks to provide exposure to the price of gold while targeting periodic distributions paid in additional ounces of gold.Rev

    11/10/25 8:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care